Here’s Why Artisan Mid Cap Fund Exited Dexcom (DXCM)
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Dexcom Inc (DXCM)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Zevenbergen Capital Investments Nancy Zevenbergen | 685,433 | $46,122,787 | +10% | 0.9% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $50.01 | 25,000 | $1,250,250.00 | 58,502 | 2017-11-07 | Filing | |
| $49.61 | 10,000 | $496,100.00 | 33,502 | 2017-11-06 | Filing | |
| $15.50 | 70,000 | $1,085,000.00 | 121,975 | 2013-03-11 | Filing | |
| $10.37 | 1,000 | $10,369.00 | 6,000 | 2012-03-08 | Filing | |
| $10.34 | 1,000 | $10,340.00 | 5,000 | 2012-03-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $80.86 | 667 | $53,933.62 | 22,667 | 2025-09-05 | Filing | |
| $80.00 | 1,466 | $117,280.00 | 105,223 | 2025-09-04 | Filing | |
| $74.17 | 4,824 | $357,796.08 | 118,657 | 2025-09-02 | Filing | |
| $80.29 | 500 | $40,145.00 | 94,102 | 2025-08-15 | Filing | |
| $81.54 | 195 | $15,900.30 | 51,121 | 2025-08-15 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 828,759 | $55,767,193 | 0.08% | |
| 2. | 310,304 | $20,880,357 | 0.88% | |
| 3. | 291,663 | $19,625,988 | 0.33% | |
| 4. | 223,978 | $15,071,479 | 0.02% | |
| 5. | 108,485 | $7,299,955 | 0.01% |
News See All
William Blair Maintains Bullish Stance on DexCom (DXCM) Stock
DexCom, Inc. (NASDAQ:DXCM) is one of the Best Long Term Growth Stocks to Buy Now.
14 Best Long Term Growth Stocks to Buy Now
Morningstar highlighted that, as of Sept. 30, 2025, the US equity market was trading at 3% premium over its fair value estimates.
TD Cowen Maintains its Buy Rating and $100 PT for DexCom, Inc. (DXCM)
On September 25, 2025, given that previous technical problems with the company’s G7 continuous glucose monitoring (CGM) technology had been fixed, TD Cowen kept its buy rating and $100 price target ...
13 Best Quality Stocks to Buy Right Now
In addition to capturing secular growth trends in technology, healthcare, and energy, quality stocks frequently show the capacity to withstand macroeconomic unpredictability, such as geopolitical tensions...
12 Best Healthcare Stocks to Buy and Hold for 5 Years
Most Americans have endured the annoyance of having their health insurance denied, frequently with no resolution even after contacting carriers via phone and email. This can be changed by Dr.
UBS Downplays G7 CGM Sensor Concerns, Affirms DexCom’s Inc. (DXCM) ‘Buy’ Rating
DexCom, Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy and hold forever. On September 22, UBS reiterated a ‘Buy’ rating on the stock and a $106 price target.
11 Best Growth Stocks to Buy and Hold Forever
Global equities are likely to continue edging higher even as valuation concerns continue to arouse fear among investors.
DexCom, Inc. (DXCM): A Bull Case Theory
We came across a bullish thesis on DexCom, Inc. on Flyover Stocks Substack by Todd Wenning. In this article, we will summarize the bulls’ thesis on DXCM.
Hedge Fund Resource Center Billionaire Hedge Funds
